![image](https://c-assets.papillon.io/image/fetch/s--YnOMApIW--/c_thumb,g_face,fl_progressive,z_0.82,h_200,q_90,w_200/https://c-assets.papillon.io/image/fetch/s--YnOMApIW--/f_auto/https://dkf1ato8y5dsg.cloudfront.net/uploads/52/504/hannouno-lthumb.jpg)
- On-demand
- About
The sector has solid fundamentals over the next several years but challenges will rise in 2026 and beyond, driving more active M&A and a focus on R&D execution
- Blockbusters product opportunities
- Patent cliff exposures
- Inflation Reduction Act & Proposed European Drug Regulations
- Biosimilar and generic drug markets
- Acquisition landscape
-
Speakers
Confirm cancellation
Something went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign In
Please sign in to your account: